Cargando…
Fluoroquinolone treatment as a protective factor for 10-day mortality in Streptococcus pneumoniae bacteremia in cancer patients
To evaluate the prognostic factors in adult cancer patients with pneumococcal bacteremia, describe episode features and the phenotypic characteristics of the isolated strains. We evaluated the episodes in patients admitted to a cancer hospital between 2009 and 2015. The outcomes were defined as 48 h...
Autores principales: | Fontana, Naihma Salum, Ibrahim, Karim Yaqub, Bonazzi, P. R., Rossi, F., Almeida, S. C. G., Tengan, F. M., Brandileone, M. C. C., Abdala, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881156/ https://www.ncbi.nlm.nih.gov/pubmed/33580101 http://dx.doi.org/10.1038/s41598-021-81415-0 |
Ejemplares similares
-
Author Correction: Fluoroquinolone treatment as a protective factor for 10-day mortality in Streptococcus pneumoniae bacteremia in cancer patients
por: Fontana, Naihma Salum, et al.
Publicado: (2021) -
Fluoroquinolone-resistant Streptococcus pneumoniae
por: Pletz, Mathias W.R., et al.
Publicado: (2006) -
Relative Fitness of Fluoroquinolone-resistant Streptococcus pneumoniae
por: Johnson, Crystal N., et al.
Publicado: (2005) -
Fluoroquinolone Resistance in Penicillin-resistant Streptococcus pneumoniae Clones, Spain
por: de la Campa, Adela G., et al.
Publicado: (2004) -
Persistence and Complex Evolution of Fluoroquinolone-Resistant Streptococcus pneumoniae Clone
por: Ben-David, Debby, et al.
Publicado: (2014)